About Haematologische Praxis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German CLL Study Group
3
German High-Grade Non-Hodgkin's Lymphoma Study Group
1
Heidelberg University
1
Hoffmann-La Roche
1
Clinical Trials at Haematologische Praxis
During the past decade, Haematologische Praxis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
2002-06-01
2017-03-31
Completed
1,551
Bendamustine and Mitoxantrone in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
2004-10-01
2009-10-01
Completed
60
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
2004-09-01
2010-10-01
Completed
97
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
2003-04-01
2011-03-01
Completed
75
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Haematologische Praxis"
#1 collaborator was "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Haematologische Praxis
According to Clinical.Site data, the most researched conditions in "Haematologische Praxis" are
"Chronic Lymphocytic Leukemia" (3 trials), "Leukemia" (2 trials), "Anemia" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Haematologische Praxis" in a lesser frequency.
Clinical Trials Intervention Types at Haematologische Praxis
Most popular intervention types in "Haematologische Praxis" are "Drug" (6 trials), "Biological" (4 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "prednisone" (2 trials), "rituximab" (2 trials) and "vincristine sulfate" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Haematologische Praxis
The vast majority of trials in "Haematologische Praxis" are
6 trials for "All" genders.
Clinical Trials Status at Haematologische Praxis
Currently, there are NaN active trials in "Haematologische Praxis".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Haematologische Praxis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Haematologische Praxis, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".